Skip to main content
OpenTrials

Clinical trial condition

Tuberculosis, Multidrug-Resistant

Explore clinical trials studying Tuberculosis, Multidrug-Resistant. Study availability and eligibility vary by location and protocol.

102 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Tuberculosis, Multidrug-Resistant trial results

Completed

Evaluating Newly Approved Drugs for Multidrug-resistant TB

NCT02754765

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations
  • National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia
  • Aundh Chest Hospital Pune, India
  • City Centre of Phthisiopulmonology Almaty, Kazakhstan
  • Center of Phthisiopulmonology of Almaty Health Department Almaty, Kazakhstan
View Trial Details
Completed

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

NCT03896685

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • Aundh Chest Hospital Pune, India
  • National Center for Tuberculosis Problems Almaty, Kazakhstan
  • State Municipal Enterprise on the right of economic management "City Centre of Phthisiopulmonology" of Nur-sultan city's administration Almaty, Kazakhstan
  • Partners In Health Lesostho Maseru, Lesotho
View Trial Details
Completed

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

NCT04179500

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia
  • CHRU, Sizwe Tropical Diseases Hospital Johannesburg, South Africa
  • Isango Lethemba TB Research Unit Empilweni TB Hospital Port Elizabeth, South Africa
  • The Aurum Institute: Rustenburg Clinical Research Centre Rustenburg, South Africa
View Trial Details
Completed

Treatment Shortening of MDR-TB Using Existing and New Drugs

NCT02619994

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine Seoul, South Korea
View Trial Details
Completed

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

NCT03867136

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • The Third People's Hospital of Shenzhen City Shenzhen, Guangzhou, China
  • Guiyang Public Health Treatment Center Guizhou, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
  • Hunan Chest Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Completed

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

NCT04717908

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • The Third People's Hospital of Shenzhen City Shenzhen, Guangzhou, China
  • Guiyang Public Health Treatment Center Guizhou, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
  • Hunan Chest Hospital Changsha, Hunan, China
View all 15 locations
View Trial Details

Related conditions